Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and
worldwide. For many decades lung cancer was the sole cancer among the deadly four without an
evidence-based screening method for decreasing mortality. This changed in November 2011 when
findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was
more efficacious in reducing deaths in high-risk individuals than conventional radiography. As
such an ever-increasing number of health organizations now recommend this screening protocol.
Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues fulfills the dire need
for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first
two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors
beyond cigarette smoking. Subsequent chapters cover the fundamentals with clinical pearls on
setting up a successful lung cancer screening program patient eligibility criteria imaging
variances of tumors in the lungs screening pros and cons and interpreting reporting screening
results. - The evolution and future of lung cancer screenings - Detection and management of
unexpected incidental pulmonary and non-pulmonary findings - Discussion of test cases utilizing
the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings - Benefits and
potential harms associated with mass lung cancer screening programs including false positive
false negative and over-diagnosis rates This state-of-the-art guide is essential reading for
radiologists oncologists pulmonologists and internists. It is a must-have bookshelf
reference for hospital radiology and oncology departments in particular for those setting up
new lung cancer screening programs.
